A prospective cohort study of the associations between gut microbiota, plasma biomarkers, and non-alcoholic fatty liver disease in obese patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300075754

Enrollment

Unknown

Registered

2023-09-14

Start date

2023-09-15

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-alcoholic fatty liver disease

Interventions

Non-alcoholic fatty liver disease:None

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria were: age 18-50 years; There is no contraindication of surgery, and elective weight-loss metabolic surgery is proposed. No long history of alcohol consumption.

Exclusion criteria

Exclusion criteria: The exclusion criteria were: patients with a history of malignant tumors; Patients with infectious liver diseases such as hepatitis and liver parasites; Have participated in other interventional clinical trials within the last 1 year; Special drugs that may damage the liver.

Design outcomes

Primary

Measure	Time frame
NAS score of NAFLD;Intestinal flora;Plasma biomarkers;Liver tissue transcriptome;	—

Countries

China

Contacts

Public ContactChen Yi

West China Hospital of Sichuan University

toddychan@163.com+86 136 6629 8257

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026